Stock ZHYBF ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhong Yuan Bio-Technology Holdings Limited

Equities

ZHYBF

KYG989A31097

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 10:40:31 2024-04-26 am EDT 		5-day change 1st Jan Change
5 USD 0.00% Intraday chart for Zhong Yuan Bio-Technology Holdings Limited -0.40% +146.31%
Mar. 25 Zhong Yuan Bio-Technology Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
2023 Zhong Yuan Bio-Technology Holdings Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI

Valuation

Fiscal Period: March 2022 2023
Capitalization 1 117.6 65.94
Enterprise Value (EV) 1 119.1 67.7
P/E ratio -103 x -29.5 x
Yield - -
Capitalization / Revenue 50.5 x 39.7 x
EV / Revenue 51.2 x 40.7 x
EV / EBITDA -106 x -54.2 x
EV / FCF 22,987 x 86.4 x
FCF Yield 0% 1.16%
Price to Book 125 x -190 x
Nbr of stocks (in thousands) 17,547 17,680
Reference price 2 6.700 3.730
Announcement Date 9/26/22 7/27/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 0.2595 1.218 1.22 1.624 2.329 1.663
EBITDA 1 -0.3977 0.3181 -0.0792 -0.008605 -1.124 -1.249
EBIT 1 -0.0456 0.3121 -0.0855 -0.0146 -1.129 -1.253
Operating Margin -17.58% 25.64% -7.01% -0.9% -48.49% -75.39%
Earnings before Tax (EBT) 1 -0.0456 0.2961 -0.0873 -0.0274 -1.114 -1.759
Net income 1 -0.0456 0.2802 -0.0873 -0.028 -1.126 -2.231
Net margin -17.58% 23.01% -7.16% -1.73% -48.34% -134.19%
EPS 2 -0.0537 0.0165 -0.005231 -0.001634 -0.0651 -0.1263
Free Cash Flow 1 -0.0207 0.2451 -0.1374 -0.4391 0.005182 0.7839
FCF margin -7.97% 20.13% -11.27% -27.03% 0.22% 47.15%
FCF Conversion (EBITDA) - 77.06% - - - -
FCF Conversion (Net income) - 87.47% - - - -
Dividend per Share - - - - - -
Announcement Date 4/28/20 9/5/19 8/17/20 8/16/21 9/26/22 7/27/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 0.05 - 0.66 1.5 1.55 1.76
Net Cash position 1 - 0.14 - - - -
Leverage (Debt/EBITDA) -0.1265 x - -8.372 x -174.9 x -1.382 x -1.406 x
Free Cash Flow 1 -0.02 0.25 -0.14 -0.44 0.01 0.78
ROE (net income / shareholders' equity) 92.4% 21.4% -5.96% -1.88% -92.2% -573%
ROA (Net income/ Total Assets) -28,515% 11.4% -2.57% -0.32% -22.4% -30.5%
Assets 1 0.00016 2.466 3.394 8.812 5.032 7.309
Book Value Per Share 2 -0.0800 0.0900 0.0900 0.0900 0.0500 -0.0200
Cash Flow per Share 2 0 0 0 0.0100 0.0100 0.0200
Capex - - 0.01 0.01 - 0.02
Capex / Sales - - 0.62% 0.35% - 1.35%
Announcement Date 4/28/20 9/5/19 8/17/20 8/16/21 9/26/22 7/27/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED Stock Zhong Yuan Bio-Technology Holdings Limited
+146.31% 88.5M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.84% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.02% 231B
NOVARTIS AG Stock Novartis AG
+4.80% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.45% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ZHYBF Stock
  4. Financials Zhong Yuan Bio-Technology Holdings Limited